Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (45)
- Biology and Soft Matter (1)
- Clean Energy (17)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Fusion and Fission (4)
- Isotopes (4)
- Materials (24)
- Materials for Computing (4)
- National Security (6)
- Neutron Science (9)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Supercomputing (35)
News Type
News Topics
- (-) Advanced Reactors (8)
- (-) Biomedical (31)
- (-) Clean Water (15)
- (-) Climate Change (52)
- (-) Exascale Computing (29)
- (-) Nanotechnology (16)
- (-) Physics (31)
- 3-D Printing/Advanced Manufacturing (43)
- Artificial Intelligence (51)
- Big Data (29)
- Bioenergy (51)
- Biology (60)
- Biotechnology (12)
- Buildings (23)
- Chemical Sciences (27)
- Composites (8)
- Computer Science (89)
- Coronavirus (17)
- Critical Materials (5)
- Cybersecurity (14)
- Decarbonization (47)
- Education (2)
- Emergency (2)
- Energy Storage (30)
- Environment (105)
- Fossil Energy (4)
- Frontier (26)
- Fusion (31)
- Grid (26)
- High-Performance Computing (48)
- Hydropower (5)
- Isotopes (31)
- ITER (2)
- Machine Learning (23)
- Materials (44)
- Materials Science (47)
- Mathematics (7)
- Mercury (7)
- Microelectronics (3)
- Microscopy (20)
- Molten Salt (1)
- National Security (47)
- Net Zero (8)
- Neutron Science (51)
- Nuclear Energy (56)
- Partnerships (21)
- Polymers (8)
- Quantum Computing (22)
- Quantum Science (32)
- Renewable Energy (1)
- Security (12)
- Simulation (33)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (31)
- Sustainable Energy (48)
- Transformational Challenge Reactor (3)
- Transportation (27)
Media Contacts
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Oak Ridge National Laboratory was among an international team, led by Lawrence Livermore National Laboratory, who synthesized 108 elevated carbon dioxide, or CO2, experiments performed in various ecosystems to find out how much carbon is
Nuclear physicist Caroline Nesaraja of the Department of Energy’s Oak Ridge National Laboratory evaluates nuclear data vital to applied and basic sciences.
Researchers at the Department of Energy’s Oak Ridge National Laboratory and the University of Tennessee are automating the search for new materials to advance solar energy technologies.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
Marcel Demarteau is director of the Physics Division at the Department of Energy’s Oak Ridge National Laboratory. For topics from nuclear structure to astrophysics, he shapes ORNL’s physics research agenda.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.